“IRAN: A GOLD MINE BEYOND OIL AND NUCLEAR POWER”

9 - minutes read |

The country’s natural wealth may extend far beyond the hydrocarbons buried beneath its territory

KRC TIMES Desk

Col (Dr.) Ashwani Kumar, MiD, VSM (Retd.)

Medicinal Biodiversity, Persian Herbal Wealth and the Emerging Geopolitics of Natural Resources.

For decades, international attention on Iran has remained concentrated on its oil and gas reserves, nuclear programme, ballistic missile capabilities and strategic influence across West Asia. The United States, Israel and other global powers have viewed Iran primarily through the prism of energy security, regional politics and military competition. But there is another dimension of Iran’s national wealth that deserves far greater attention: its extraordinary biodiversity, medicinal plants, natural resins, pharmaceutical resources and centuries-old Persian medical knowledge.

Could Iran be sitting on a gold mine that the world has not fully recognised?.

This question deserves serious investigation. The country’s natural wealth may extend far beyond the hydrocarbons buried beneath its territory. Its mountains, forests, plains and semi-arid regions contain thousands of plant species with potential applications in pharmaceuticals, biotechnology, cosmetics, nutraceuticals and modern medical research.

Iran’s Extraordinary Biological Wealth.

Iran possesses an exceptionally diverse natural environment. A scientific study published in 2022 in the International Journal of Environmental Research and Public Health estimated that the country has approximately 8,200 vascular plant species, including around 2,300 medicinal and aromatic plant species. The study also identified 180 endemic medicinal and aromatic species. The Zagros Mountains, Alborz ranges, Khorasan region and other ecological zones provide different climatic conditions that support a remarkable variety of medicinal plants.
This diversity represents more than an environmental asset. It is a potential economic and scientific resource.

The question is whether Iran has developed the scientific infrastructure, pharmaceutical industries and international marketing capabilities necessary to convert this biological wealth into national prosperity.

The Persian Heritage of Medicinal Plants.

Persian civilisation has a long history of herbal medicine. Traditional knowledge developed through generations of observation, experimentation and medicinal practices. Several plants and natural substances associated with Persian medicine continue to attract international commercial and scientific interest.

Saffron is perhaps the most recognised example. Iran has historically been one of the world’s leading producers and exporters of this precious spice.

But saffron is only one part of the story.

Other important resources include Persian borage, asafoetida, galbanum, tragacanth, liquorice, Persian shallot and several aromatic and mountain medicinal plants. Their commercial significance extends across pharmaceutical preparations, natural extracts, essential oils, food processing, cosmetics and traditional medicine.

Some of their chemical constituents may also provide starting points for future pharmaceutical research. However, their therapeutic effectiveness must be established through proper scientific investigation rather than traditional reputation alone.

Ten Natural Resources Worth Investigating

A serious study of Iranian biological wealth should examine the following resources:

Saffron (Crocus sativus): Iran’s internationally recognised agricultural treasure, particularly associated with the Khorasan region. Its principal chemical constituents, including crocin and safranal, have attracted considerable scientific research. Persian Borage (Echium amoenum): A traditional Persian herbal plant used in herbal infusions and investigated for its phytochemical and pharmacological properties.

Know More https://bit.ly/KRCBrainVision Apply Here https://bit.ly/KRCBVForm
Promotional | For admission to the Brain Vision Program | Know More | Apply Here

Asafoetida (Ferula assa-foetida): A valuable medicinal and aromatic resin with traditional digestive applications and potential pharmaceutical uses.

Galbanum (Ferula gummosa): An aromatic resin of commercial importance in perfumery, traditional preparations and natural-product research.

Golpar (Heracleum persicum): A Persian aromatic plant traditionally used in food and herbal preparations.

Persian Shallot (Allium hirtifolium): A distinctive Iranian plant investigated for its antioxidant and other biological properties.

Tragacanth (Astragalus species): A natural gum with applications in pharmaceutical formulations, food technology and cosmetics.

Liquorice (Glycyrrhiza glabra): A source of glycyrrhizin and other compounds used in pharmaceutical and food industries. Its safety also requires attention because excessive consumption can cause serious adverse effects.

Keluss (Kelussia odoratissima): A distinctive Iranian mountain plant with ethnobotanical and conservation significance.

Kakuti-e-Irani (Ziziphora persica): An aromatic plant whose essential oils and biological properties deserve further scientific investigation.

These resources should be evaluated for their geographical origins, availability, chemical composition, commercial value and potential for sustainable cultivation. Not all are exclusive to Iran; their actual distribution and Iranian traditional significance must be distinguished.

Akarkara, Salam Panja and Salam Mishri: A Case for Botanical Accuracy

Three medicinal substances frequently discussed in Indian and Unani markets deserve special attention: Iranian Akarkara, Salam Panja and Salam Mishri. They are traditionally associated with medicinal preparations intended for vitality, physical strength and reproductive health. Their commercial reputation has created considerable interest among herbal traders and consumers.

However, their geographical origins must be established accurately.

Akarkara, commonly identified as Anacyclus pyrethrum, is native principally to Spain, Morocco and Algeria according to botanical records. Its appearance in Iranian medicinal markets does not establish that it originated in Iran.

Salam Panja, generally identified as Dactylorhiza hatagirea, is a Himalayan medicinal orchid found across parts of the Himalayan region and neighbouring areas, including Afghanistan. It is threatened by overharvesting and habitat degradation.

Salam Mishri is even more complicated. The name is used in herbal trade for different botanical species, making authentication essential before any medicinal or commercial claim can be made.

These three substances should therefore form a separate comparative investigation into Persian, Afghan, Himalayan and Indian medicinal trade rather than being automatically classified as Iranian-origin plants.

This distinction is important. A country may trade in, process or use a medicinal plant without being its place of origin. Rising Prices and the Commercial Exploitation of the Iranian Label

An interesting development has been observed in the Indian herbal market since the outbreak of the Iran conflict. Products such as Akarkara, Salam Panja and Salam Mishri, frequently promoted and sold under the label of Iranian medicinal herbs, have reportedly witnessed a substantial increase in their market prices. In some retail outlets and online herbal markets, these products are being offered at approximately Rs 400 for just 10 grams. If such pricing is widespread, it raises serious questions about the actual cost of procurement, authenticity, supply chains and the margins being earned by traders.

The more concerning aspect is the manner in which these products are being marketed. Their association with Iran, Persian medicinal heritage and traditional claims relating to physical strength, stamina and reproductive health is increasingly being used as a selling point. Social media advertisements, promotional videos and exaggerated claims about their medicinal benefits are creating an impression that these are rare, imported and exceptionally powerful Iranian products. Consumers, often without access to reliable botanical information or independent quality verification, may end up paying considerably more than the actual value of the material warrants.

This raises an uncomfortable question: are sections of the Indian business community exploiting the geopolitical situation and the growing public interest in Iranian products to create an artificial premium in the herbal market? Are consumers actually purchasing authenticated Iranian imports, or are they buying locally sourced, substituted or inadequately identified plant material marketed under an attractive foreign identity?

There is also a fundamental botanical issue. Akarkara, generally identified as Anacyclus pyrethrum, is native principally to North Africa and parts of the Mediterranean region. Salam Panja, generally identified as Dactylorhiza hatagirea, is a Himalayan medicinal orchid. Salam Mishri is a variable trade name associated with different botanical species. Their sale under an Iranian label does not, by itself, establish Iranian geographical origin or authenticity.

The concern is therefore not merely about high prices. It is about the possibility of consumer deception through misleading origin claims, exaggerated medicinal advertisements and the commercial exploitation of traditional knowledge. Relevant authorities should examine product labelling, botanical identification, country-of-origin declarations, import documentation, quality certification and advertising claims. Consumers also deserve to know exactly what they are buying, where it comes from and whether its claimed medicinal properties have any reliable scientific basis.

A product cannot become Iranian merely because the seller gives it an Iranian identity, nor can a high price establish superior medicinal quality. The growing popularity of these products must not become an opportunity for unscrupulous traders to exploit public curiosity, geopolitical developments and consumer trust. The real need is transparency, scientific authentication and responsible trade.

China and America: Who Is Buying Iranian Natural Wealth?

The international trade in Iranian medicinal and agricultural products provides an important starting point for understanding the economic significance of these resources.

Saffron offers a particularly useful example.

According to World Bank World Integrated Trade Solution data based on UN Comtrade, Iran exported saffron worth approximately US$253 million in 2023. China was a major destination, purchasing approximately US$80.3 million worth, representing nearly 69.8 tonnes.

This demonstrates that Iranian natural products already have substantial international commercial value.

The American market presents a different picture.

Iranian saffron has historically been reported as reaching the United States. However, international sanctions have complicated direct trade. A 2019 report quoting an Iranian agricultural official identified the United States among the destinations for Iranian saffron. Such reporting establishes a historical export connection, although it does not by itself establish the volume of direct American purchases or the extent of indirect trade through third countries.

China’s documented commercial purchases and the broader international pharmaceutical industry’s interest in natural compounds make this an important area for further research.

Nevertheless, purchasing a product does not automatically establish an intention to control its source country or its natural resources.

The Greater Prize: Pharmaceutical Research and Intellectual Property

The real economic value of medicinal plants may not lie in the raw material itself.

It may lie in what science can extract, identify, develop and commercialise from that material.

A kilogram of raw medicinal plant may have a limited market value. A purified chemical compound, standardised extract, patented formulation or clinically validated pharmaceutical product derived from natural substances can command a much higher commercial value.

This creates an important distinction between possessing biological resources and controlling the technology that converts them into profitable products.

A country may supply the original plant material, while foreign companies undertake laboratory research, develop extraction technologies, register intellectual property and control international distribution. The original supplier may receive only a small proportion of the final commercial value. This is where the issue of biopiracy, genetic-resource ownership and equitable benefit-sharing becomes important.

The Convention on Biological Diversity recognises national sovereignty over biological resources and provides a framework for access and benefit-sharing. Iran must therefore consider whether its traditional knowledge and biological resources are adequately protected when foreign research organisations and commercial enterprises investigate them.

Is There a Hidden American Agenda?

The strategic importance of Iran to the United States is well known. Oil, nuclear capabilities, regional security, Israel’s security and Iran’s relationships with Russia and China have dominated American policy discussions. But should the possibility of competition over biological resources and pharmaceutical knowledge also be examined?

Certainly.

The United States has one of the world’s most advanced pharmaceutical and biotechnology industries. China is also investing heavily in biotechnology, pharmaceutical research and traditional medicine.

Both countries have commercial and scientific reasons to be interested in valuable natural compounds, genetic resources and medicinal plants. However, there is presently no established documentary evidence that taking control of Iran’s medicinal biodiversity is a hidden objective of American military or foreign policy.

The more credible research question is whether foreign commercial and scientific interests could create economic dependence, unequal intellectual-property ownership or the exploitation of Iranian traditional knowledge. That question deserves investigation through patent records, corporate investments, research agreements, import-export statistics and international trade arrangements.

It would be premature to describe such competition as an established military agenda.

What Is More Valuable Than Oil?

The question of whether medicinal plants and their derivatives can be more valuable than oil requires a distinction between volume, market value and strategic importance.

Oil is traded in enormous quantities and remains one of the world’s most important commodities. No responsible assessment can conclude that Iran’s medicinal plants collectively are worth more than its petroleum reserves without a detailed economic valuation.

But individual natural compounds, specialised pharmaceutical ingredients and patented medicines can command exceptionally high prices relative to the raw biological material from which they originate. The value is created through scientific research, processing, intellectual property, clinical validation and access to international markets.

The same principle applies to certain natural resins, essential oils and specialised plant extracts.

Therefore, the real question is not whether a medicinal plant is more expensive than a barrel of oil. It is whether the scientific and commercial value developed from biological resources can create a sustainable, high-value industry that reduces dependence on conventional commodity exports.

Iran has considerable potential in this direction. Iran Must Protect Its Biological Sovereignty. Iran’s economic future should not depend exclusively on oil and gas exports. The country has an opportunity to develop a high-value medicinal-plant and pharmaceutical sector through scientific research, cultivation, processing, quality certification and international marketing.

Instead of exporting raw plants and resins, Iran could invest in extraction facilities, pharmaceutical research laboratories, standardised formulations and biotechnology enterprises. It should also establish a comprehensive national database of medicinal plants, protect endemic species, document traditional knowledge and ensure that local communities receive a fair share of the commercial benefits.

Unregulated harvesting is another serious concern. Some medicinal orchids and other rare plants are already threatened by excessive collection. The commercialisation of natural resources without conservation measures can destroy the very wealth that creates their market value.

Col (Dr.) Ashwani Kumar, MiD, VSM (Retd) . CEO, Sharda Sarvagya Peeth, Jammu & Kashmir.

Iran’s biological heritage must be protected as carefully as its oil reserves, mineral resources and strategic infrastructure.

Conclusion: The Wealth That Grows Above the Ground

International politics often measures a country’s power through oil reserves, military strength, nuclear capabilities and geographical influence. But the coming decades may also be shaped by biotechnology, pharmaceutical innovation, genetic resources and the commercial value of biodiversity.

Iran possesses a remarkable foundation for participating in this emerging competition.

Its medicinal plants, natural resins, aromatic resources and Persian medical heritage could provide opportunities for scientific innovation, economic diversification and international trade. The question is not whether America or China has a secret plan to seize Iran’s medicinal plants. That claim requires evidence.

The more important question is whether Iran fully understands the value of what it possesses and whether it is prepared to protect, research and commercialise these resources before others capture the greater economic benefits.

Oil lies beneath the ground, but biological wealth grows above it.

A nation that protects its natural resources, develops its scientific capabilities and retains ownership of its intellectual property can convert biodiversity into economic strength.

Iran may indeed be a gold mine beyond oil and nuclear power. Its greatest challenge is to ensure that the wealth growing on its land becomes a source of prosperity for its own people.


About the Author

Col (Dr.) Ashwani Kumar, MiD, VSM (Retd.), is a former Indian Army officer and senior government functionary with experience in defence, intelligence, strategic affairs and national security. He writes on geopolitics, military affairs, history and issues of national and international strategic importance.

Disclaimer

This article is an independent research-based analysis. It distinguishes established scientific and trade information from questions requiring further investigation. References to possible foreign strategic interests are analytical hypotheses and should not be interpreted as established evidence of a covert state policy.

Leave a comment

Your email address will not be published. Required fields are marked *

×

Hello!

Click one of our contacts below to chat on WhatsApp

× How can I help you?